Masimo Corporation (MASI)

Market Cap	8.87B
Revenue (ttm)	2.13B
Net Income (ttm)	-494.50M
Shares Out	54.22M
EPS (ttm)	-9.23
PE Ratio	n/a
Forward PE	33.22
Dividend	n/a
Ex-Dividend Date	n/a

Volume	614,205
Open	162.41
Previous Close	156.57
Day's Range	161.72 - 165.28
52-Week Range	101.61 - 194.88
Beta	1.23
Analysts	Buy
Price Target	187.00 (+14.33%)
Earnings Date	May 6, 2025

About MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 8, 2007
• Employees: 3,600
• Stock Exchange: NASDAQ
• Ticker Symbol: MASI
• Website: https://www.masimo.com

Analyst Forecast

According to 6 analysts, the average rating for MASI stock is "Buy." The 12-month stock price forecast is $187.0, which is an increase of 14.33% from the latest price.

Price Target

$187.0

(14.33% upside)

Analyst Consensus: Buy